The prevalence of men-1 in Tasmania

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 3, 1996, Pages 141-143

  Wilkinson, S ^a   Young, M ^a   Shepherd, J J ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

MEN 1; Multiple Endocrine Neoplasia Type 1; Prevalence

Indexed keywords

ALKALINE PHOSPHATASE; BICARBONATE; CALCIUM; CHLORIDE; PHOSPHATE; SERUM ALBUMIN;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; AUSTRALIA; BLOOD; CHILD; FOLLOW UP; GENETICS; HEALTH CARE ORGANIZATION; HUMAN; MASS SCREENING; MULTIPLE ENDOCRINE NEOPLASIA; PREVALENCE; RISK FACTOR;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; BICARBONATES; CALCIUM; CHILD; CHLORIDES; FOLLOW-UP STUDIES; HEALTH CARE RATIONING; HUMANS; MASS SCREENING; MEDICAL HISTORY TAKING; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PHOSPHATES; PREVALENCE; RISK FACTORS; SERUM ALBUMIN; TASMANIA;

EID: 0030096158     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85.
2. Weber G, Friedman E, Grimond S et al. The phospholipase Cβ3 gene allocated in the MEN1 region shows loss of expression in endocrine tumours. Human Molec. Gen. 1994; 3: 1775-81.
3. Vasen HFA, Lamers CBHW, Lips CJM. Screening for the Multiple Endocrine Neoplasia Syndrome Type I. Arch. Int. Med. 1989; 149: 2712-22.
4. Shepherd JJ. Latent familial multiple endocrine neoplasia in Tasmania. Med. J. Aust. 1985; 142: 395-7.
5. Shepherd JJ. The natural history of Multiple Endocrine Neoplasia Type 1. Highly uncommon or highly unrecognized. Arch. Surg. 1991; 126: 935-52.
6. Fitzpatrick LA. Hypercalcemia in the multiple endocrine neoplasia syndromes. Endo. Met. Clin. N. Amer. 1989; 18: 741-52.
7. Snyder N, Scurry MT, Deiss WP. Five families with multiple endocrine adenomatosis. Ann. Int. Med. 1972; 76: 53-8.
8. Greene BM, Golladay ES, Mollitt DL. Multiple endocrine adenopathy. Surg. Gyne. Obstet. 1983; 156: 665-76.
9. Berdjis CC. Pluriglandular syndrome. Oncologia 1962; 15: 288-311.
10. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism - Incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 1980; 302: 189-93.
11. Boonstra CE, Jackson CE. Serum calcium: Survey for hyperparathyroidism: Results in 50 000 clinic patients. Am. J. Clin. Pathol. 1971; 55: 523-6.
12. Knudson AG, Meadows AT, Nichols WWHR. Chromosome deletion and retinoblastoma. N. Engl. J. Med. 1976; 295: 1120.
13. Teh BT, Hayward NK, Wilkinson S, Woods GM, Cameron D, Shepherd JJ. Clonal loss of Int-2 alleles in sporadic and familial pancreatic endocrine tumours. Br. J. Cancer 1990; 62: 253-4.